Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice: ANP for pulmonary fibrosis

BACKGROUND: Pulmonary fibrosis is a life-threatening disease characterized by progressive dyspnea and worsening pulmonary function. Atrial natriuretic peptide (ANP), a heart-derived secretory peptide used clinically in Japan for the treatment of acute heart failure, exerts a wide range of protective...

Full description

Saved in:
Bibliographic Details
Published in:Respir Res
Main Authors: Okamoto, Atsuko, Nojiri, Takashi, Konishi, Kazuhisa, Tokudome, Takeshi, Miura, Koichi, Hosoda, Hiroshi, Hino, Jun, Miyazato, Mikiya, Kyomoto, Yohkoh, Asai, Kazuhisa, Hirata, Kazuto, Kangawa, Kenji
Format: Artigo
Language:Inglês
Published: BioMed Central 2017
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5210263/
https://ncbi.nlm.nih.gov/pubmed/28049526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0492-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items